Curcumin compound reactivates Epstein–Barr virus, offering safer cancer therapy

A novel curcumin derivative, C210, activates the Epstein–Barr virus (EBV) lytic cycle without producing infectious virions by disrupting HSP90. This discovery opens avenues for safer EBV-positive cancer therapies.

Exploring pharmacological, non-pharmacological, and stem cell therapies for treatment of autism spectrum disorders

A research study, led by Maurizio Battino and Francesca Giampieri, with a group of researchers from the Universidad Europea del Atlántico (European University of the

January 28, 2024

Ozempic Overdoses; Diabetes Supplement Warning; Sen. Sanders Blames Food Industry

Poison centers reported a sharp increase in calls related to accidental overdoses of the diabetes and weight-loss drug semaglutide (Ozempic, Wegovy). (CNN) Some patients with

December 20, 2023

Ibogaine’s Surge in Popularity Could Be a Huge Loss for the Gabonese People Unless We Shift Course – Psychedelic Alpha

Although early in its developmental process, Colorado has stated plans to move forward with legalising ibogaine services as soon as 2026. Although Colorado’s plans are

June 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.